stocks logo

GOCO Valuation

Gohealth Inc
$
3.820
-0.14(-3.535%)1D

GOCO Relative Valuation

GOCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOCO is overvalued; if below, it's undervalued.
Intellectia AI SwingMax

Historical Valuation

Gohealth Inc (GOCO) is now in the Fair zone, suggesting that its current forward PS ratio of 3.96 is considered Fairly compared with the five-year average of -16.92. The fair price of Gohealth Inc (GOCO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:3.82
Fair
-2.05
PE
1Y
3Y
5Y
Trailing
Forward
6.32
EV/EBITDA
Gohealth Inc. (GOCO) has a current EV/EBITDA of 6.32. The 5-year average EV/EBITDA is 11.07. The thresholds are as follows: Strongly Undervalued below -1.31, Undervalued between -1.31 and 4.88, Fairly Valued between 17.27 and 4.88, Overvalued between 17.27 and 23.46, and Strongly Overvalued above 23.46. The current Forward EV/EBITDA of 6.32 falls within the Historic Trend Line -Fairly Valued range.
52.80
EV/EBIT
Gohealth Inc. (GOCO) has a current EV/EBIT of 52.80. The 5-year average EV/EBIT is -1.40. The thresholds are as follows: Strongly Undervalued below -112.65, Undervalued between -112.65 and -57.02, Fairly Valued between 54.23 and -57.02, Overvalued between 54.23 and 109.86, and Strongly Overvalued above 109.86. The current Forward EV/EBIT of 52.80 falls within the Historic Trend Line -Fairly Valued range.
3.96
PS
Gohealth Inc. (GOCO) has a current PS of 3.96. The 5-year average PS is 0.31. The thresholds are as follows: Strongly Undervalued below -0.47, Undervalued between -0.47 and -0.08, Fairly Valued between 0.70 and -0.08, Overvalued between 0.70 and 1.09, and Strongly Overvalued above 1.09. The current Forward PS of 3.96 falls within the Strongly Overvalued range.
33.80
P/OCF
Gohealth Inc. (GOCO) has a current P/OCF of 33.80. The 5-year average P/OCF is 0.28. The thresholds are as follows: Strongly Undervalued below -36.22, Undervalued between -36.22 and -17.97, Fairly Valued between 18.52 and -17.97, Overvalued between 18.52 and 36.77, and Strongly Overvalued above 36.77. The current Forward P/OCF of 33.80 falls within the Overvalued range.
-2.18
P/FCF
Gohealth Inc. (GOCO) has a current P/FCF of -2.18. The 5-year average P/FCF is 1.55. The thresholds are as follows: Strongly Undervalued below -29.59, Undervalued between -29.59 and -14.02, Fairly Valued between 17.12 and -14.02, Overvalued between 17.12 and 32.69, and Strongly Overvalued above 32.69. The current Forward P/FCF of -2.18 falls within the Historic Trend Line -Fairly Valued range.
Gohealth Inc (GOCO) has a current Price-to-Book (P/B) ratio of 0.23. Compared to its 3-year average P/B ratio of 0.49 , the current P/B ratio is approximately -53.13% higher. Relative to its 5-year average P/B ratio of 0.87, the current P/B ratio is about -73.25% higher. Gohealth Inc (GOCO) has a Forward Free Cash Flow (FCF) yield of approximately -95.07%. Compared to its 3-year average FCF yield of 2.86%, the current FCF yield is approximately -3426.65% lower. Relative to its 5-year average FCF yield of -55.61% , the current FCF yield is about 70.96% lower.
0.23
P/B
Median3y
0.49
Median5y
0.87
-95.07
FCF Yield
Median3y
2.86
Median5y
-55.61
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for GOCO's competitors is 10.26, providing a benchmark for relative valuation. Gohealth Inc Corp (GOCO) exhibits a P/S ratio of 3.96, which is -61.39% above the industry average. Given its robust revenue growth of -11.17%, this premium appears unsustainable.
AI Stock Picker

Performance Decomposition

1Y
3Y
5Y
Market capitalization of GOCO decreased by 70.18% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -56.03 to -123.33.
The secondary factor is the Revenue Growth, contributed -11.17%to the performance.
Overall, the performance of GOCO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
-11.17%
105.87M → 94.05M
Revenue Growth
+
120.11%
-56.03 → -123.33
Margin Expansion
+
-179.12%
1.72 → -1.36
P/E Change
=
-70.18%
12.81 → 3.82
Mkt Cap Growth

FAQ

arrow icon

Is Gohealth Inc (GOCO) currently overvalued or undervalued?

Gohealth Inc (GOCO) is now in the Fair zone, suggesting that its current forward PS ratio of 3.96 is considered Fairly compared with the five-year average of -16.92. The fair price of Gohealth Inc (GOCO) is between to according to relative valuation methord.
arrow icon

What is Gohealth Inc (GOCO) fair value?

arrow icon

How does GOCO's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Gohealth Inc (GOCO) as of Nov 04 2025?

arrow icon

What is the current FCF Yield for Gohealth Inc (GOCO) as of Nov 04 2025?

arrow icon

What is the current Forward P/E ratio for Gohealth Inc (GOCO) as of Nov 04 2025?

arrow icon

What is the current Forward P/S ratio for Gohealth Inc (GOCO) as of Nov 04 2025?